San Juan Basin Royalty Financials - Benzinga

San Juan Basin Royalty Trust

SJTNYSE

Trade with Public

Trade with Public

$2.96

0.062.07%

At close: Sep 4, 5:00 PM EST

$2.90

-0.0649-2.19%

After Hours: Sep 3, 7:00 AM EST

Overview News Earnings ForecastFinancialsSentiment Ownership Dividends Compare Options Stock Report

San Juan Basin Royalty Financials

San Juan Basin Royalty (SJT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
San Juan Basin Royalty Q1 EPS $(0.01), Sales $201.000 Down From $8.238K YoY

San Juan Basin Royalty (NYSE:SJT) reported quarterly losses of $(0.01) per share. The company reported $201.000 in sales this quarter. This is a 97.56 percent decrease over sales of $8.238 thousand the same period last

Benzinga Newsdesk

PRO
San Juan Basin Royalty Q2 EPS $(0.00) Down From $0.02 YoY, Sales $2.985K Down From $1.892M YoY

San Juan Basin Royalty (NYSE:SJT) reported quarterly losses of $(0.00) per share. This is a 115 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $2.985 thousand in

Benzinga Newsdesk

PRO
San Juan Basin Royalty Q4 EPS $0.08 Down From $0.62 YoY, Sales $4.01M Down From $29.09M YoY

San Juan Basin Royalty (NYSE:SJT) reported quarterly earnings of $0.08 per share. This is a 87.1 percent decrease over earnings of $0.62 per share from the same period last year. The company reported $4.01 million in

Benzinga Newsdesk

Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views

U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday.

Lisa Levin

Mid-Afternoon Market Update: Nasdaq Drops Over 100 Points; Apellis Pharmaceuticals Shares Spike Higher

Toward the end of trading Monday, the Dow traded down 0.21% to 34,310.36 while the NASDAQ fell 0.86% to 13,314.36. The S&P also fell, dropping 0.42% to 4,156.26.

Lisa Levin

Earnings Scheduled For March 31, 2021

Companies Reporting Before The Bell • Apyx Medical (NASDAQ:APYX) is likely to report quarterly loss at $0.11 per share on revenue of $9.62 million.

Benzinga Insights